Prescription Price Gouging

Beleaguered pharmaceutical company, Valeant coming under fire Wednesday on Capitol Hill. Some members of the company’s management team appearing in front of the Senate Special Committee on Aging – about dramatic price increases on some of its critical life-saving medications – a practice criticized by some in Washington as unethical.

Valeant’s outgoing Chief Executive – J. Michael Pearson came clean with the Committee – saying while his company has done several things which he’s proud of, it’s also made a few mistakes.

ABC’s Megan Hughes joined us from Washington D.C.

SHARE
News Talk Florida Staff